Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;25(2):47-60.
doi: 10.1080/15265161.2023.2276161. Epub 2023 Nov 27.

Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?

Carolyn Riley Chapman  1 , Gwendolyn P Quinn  1 , Heini M Natri  2 , Courtney Berrios  3   4 , Patrick Dwyer  5 , Kellie Owens  1 , Síofra Heraty  6 , Arthur L Caplan  1
Affiliations

Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?

Carolyn Riley Chapman et al. Am J Bioeth. 2025 Feb.

Abstract

Harms and risks to groups and third-parties can be significant in the context of research, particularly in data-centric studies involving genomic, artificial intelligence, and/or machine learning technologies. This article explores whether and how United States federal regulations should be adapted to better align with current ethical thinking and protect group interests. Three aspects of the Common Rule deserve attention and reconsideration with respect to group interests: institutional review board (IRB) assessment of the risks/benefits of research; disclosure requirements in the informed consent process; and criteria for waivers of informed consent. In accordance with respect for persons and communities, investigators and IRBs should systematically consider potential group harm when designing and reviewing protocols, respectively. Research participants should be informed about any potential group harm in the consent process. We call for additional public discussion, empirical research, and normative analysis on these issues to determine the right regulatory and policy path forward.

Keywords: Group harm; big data; genetic research; genomic research; informed consent; institutional review board; research ethics.

PubMed Disclaimer

Comment in

References

    1. Academy of Medical Sciences. 2018. Our data-driven future in healthcare: people and partnerships at the heart of health related technologies. Accessed August 1, 2023. https://acmedsci.ac.uk/file-download/74634438.
    1. Akselrod O 2021. How artificial intelligence can deepen racial and economic inequalities. American Civil Liberties Union (ACLU) website, July 13. Accessed April 13, 2023. https://www.aclu.org/news/privacy-technology/how-artificial-intelligence...
    1. Appelbaum PS, Roth LH, Lidz CW, Benson P, and Winslade W. 1987. False hopes and best data: consent to research and the therapeutic misconception. The Hastings Center Report 17 (2): 20–24. doi: 10.2307/3562038. - DOI - PubMed
    1. Around Him D, Aguilar TA, Frederick A, Larsen H, Seiber M, and Angal J. 2019. Tribal IRBs: A framework for understanding research oversight in American Indian and Alaska Native communities. American Indian and Alaska Native Mental Health Research 26 (2): 71–95. - PubMed
    1. Bailey S 2021. Stop Spectrum 10K. change.org website. Accessed April 13, 2023. https://www.change.org/p/university-of-cambridge-stop-spectrum-10k

LinkOut - more resources